These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37301762)

  • 1. Stimulation of the Hydroxycarboxylic Acid Receptor 2 With the Ketone Body 3-Hydroxybutyrate and Niacin in Patients With Chronic Heart Failure: Hemodynamic and Metabolic Effects.
    Gopalasingam N; Christensen KH; Berg Hansen K; Nielsen R; Johannsen M; Gormsen LC; Boedtkjer E; Nørregaard R; Møller N; Wiggers H
    J Am Heart Assoc; 2023 Jun; 12(12):e029849. PubMed ID: 37301762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.
    Nielsen R; Møller N; Gormsen LC; Tolbod LP; Hansson NH; Sorensen J; Harms HJ; Frøkiær J; Eiskjaer H; Jespersen NR; Mellemkjaer S; Lassen TR; Pryds K; Bøtker HE; Wiggers H
    Circulation; 2019 Apr; 139(18):2129-2141. PubMed ID: 30884964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantiomer-Specific Cardiovascular Effects of the Ketone Body 3-Hydroxybutyrate.
    Gopalasingam N; Moeslund N; Christensen KH; Berg-Hansen K; Seefeldt J; Homilius C; Nielsen EN; Dollerup MR; Alstrup Olsen AK; Johannsen M; Boedtkjer E; Møller N; Eiskjær H; Gormsen LC; Nielsen R; Wiggers H
    J Am Heart Assoc; 2024 Apr; 13(8):e033628. PubMed ID: 38563382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic Effects of Ketone Bodies in Patients With Pulmonary Hypertension.
    Nielsen R; Christensen KH; Gopalasingam N; Berg-Hansen K; Seefeldt J; Homilius C; Boedtkjer E; Andersen MJ; Wiggers H; Møller N; Bøtker HE; Mellemkjær S
    J Am Heart Assoc; 2023 May; 12(10):e028232. PubMed ID: 37183871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
    Boden G; Chen X
    Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure.
    Pietschner R; Kolwelter J; Bosch A; Striepe K; Jung S; Kannenkeril D; Ott C; Schiffer M; Achenbach S; Schmieder RE
    Cardiovasc Diabetol; 2021 Nov; 20(1):219. PubMed ID: 34753480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility.
    Homilius C; Seefeldt JM; Axelsen JS; Pedersen TM; Sørensen TM; Nielsen R; Wiggers H; Hansen J; Matchkov VV; Bøtker HE; Boedtkjer E
    Basic Res Cardiol; 2023 Sep; 118(1):37. PubMed ID: 37688627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ketone body 3-hydroxybutyrate on cardiac and mitochondrial function during donation after circulatory death heart transplantation.
    Seefeldt JM; Libai Y; Berg K; Jespersen NR; Lassen TR; Dalsgaard FF; Ryhammer P; Pedersen M; Ilkjaer LB; Hu MA; Erasmus ME; Nielsen RR; Bøtker HE; Caspi O; Eiskjær H; Moeslund N
    Sci Rep; 2024 Jan; 14(1):757. PubMed ID: 38191915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating 3-hydroxy butyrate predicts mortality in patients with chronic heart failure with reduced ejection fraction.
    Christensen KH; Nielsen RR; Schou M; Gustafsson I; Jorsal A; Flyvbjerg A; Tarnow L; Bøtker HE; Kistorp C; Johannsen M; Møller N; Wiggers H
    ESC Heart Fail; 2024 Apr; 11(2):837-845. PubMed ID: 38196294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 3-hydroxybutyrate on posttraumatic metabolism in man.
    Hiraide A; Katayama M; Sugimoto H; Yoshioka T; Sugimoto T
    Surgery; 1991 Feb; 109(2):176-81. PubMed ID: 1992551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ketone body infusion on plasma growth hormone and glucagon in man.
    Quabbe HJ; Trompke M; Luyckx AS
    J Clin Endocrinol Metab; 1983 Sep; 57(3):613-8. PubMed ID: 6348066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Effects of Ketone Ester in Patients With Cardiogenic Shock: A Randomized, Controlled, Double-Blind Trial.
    Berg-Hansen K; Christensen KH; Gopalasingam N; Nielsen R; Eiskjær H; Møller N; Birkelund T; Christensen S; Wiggers H
    JACC Heart Fail; 2023 Oct; 11(10):1337-1347. PubMed ID: 37452805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketone Body, 3-Hydroxybutyrate: Minor Metabolite - Major Medical Manifestations.
    Møller N
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32525972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2.
    Graff EC; Fang H; Wanders D; Judd RL
    Metabolism; 2016 Feb; 65(2):102-13. PubMed ID: 26773933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating beta-hydroxybutyrate levels in advanced heart failure with reduced ejection fraction: Determinants and prognostic impact.
    Monzo L; Kovar J; Borlaug BA; Benes J; Kotrc M; Kroupova K; Jabor A; Franekova J; Melenovsky V
    Eur J Heart Fail; 2024 Jun; ():. PubMed ID: 38853653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling.
    Voros G; Ector J; Garweg C; Droogne W; Van Cleemput J; Peersman N; Vermeersch P; Janssens S
    Circ Heart Fail; 2018 Dec; 11(12):e004953. PubMed ID: 30562098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy.
    Plecko B; Stoeckler-Ipsiroglu S; Schober E; Harrer G; Mlynarik V; Gruber S; Moser E; Moeslinger D; Silgoner H; Ipsiroglu O
    Pediatr Res; 2002 Aug; 52(2):301-6. PubMed ID: 12149510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic exposure to ketone bodies impairs glucose uptake in adult cardiomyocytes in response to insulin but not vanadate: the role of PI3-K.
    Pelletier A; Tardif A; Gingras MH; Chiasson JL; Coderre L
    Mol Cell Biochem; 2007 Feb; 296(1-2):97-108. PubMed ID: 16960657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Acutely Increased Endogenous- and Exogenous Ketone Bodies on FGF21 Levels in Humans.
    Lauritzen ES; Svart MV; Voss T; Møller N; Bjerre M
    Endocr Res; 2021 Feb; 46(1):20-27. PubMed ID: 33074729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.